CRKL and cancer: Analysis of the curated set of non-redundant studies in The Cancer Genome Atlas (TCGA) using the cBioPortal platform [104,105] indicates that only 0.5% and 1% of cancer patients showed copy number increases for CRK and CRKL, respectively.